Skip to main content
Contact Us
Subscribe
E-Edition
67°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Medipharm Labs Corp
(TSX:
LABS
)
0.0700
+0.0050 (+7.69%)
Streaming Delayed Price
Updated: 1:10 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Medipharm Labs Corp
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
August 14, 2024
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now
August 09, 2024
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
July 03, 2024
Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
June 20, 2024
Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
May 15, 2024
Via
Benzinga
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
March 27, 2024
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,...
Via
Benzinga
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
February 07, 2024
Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
December 22, 2023
This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
November 14, 2023
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of...
Via
Benzinga
MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M
October 02, 2023
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dis
Via
Benzinga
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
September 20, 2023
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C.
Via
Benzinga
MediPharm Labs Sees 16.5% QoQ Increase In International Medical Cannabis Sales, Announces New CEO
November 15, 2021
CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director
October 21, 2021
MediPharm Labs Corp. (TSX:LABS) (OTCQX:
Via
Benzinga
MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia
August 31, 2021
MediPharm Labs Corp. (TSX:LABS) (OTCQX:
Via
Benzinga
MediPharm Labs Reports 24% QoQ Pop In International Sales, Q2 2021 Revenue Drops 63.6% YoY
August 16, 2021
MediPharm Labs Corp. (TSX:LABS) (OTCQX:
Via
Benzinga
MediPharm Labs Receives Canadian GMP Pharmaceutical Drug Establishment License
July 14, 2021
Pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQX...
Via
Benzinga
MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma
June 08, 2021
MediPharm Labs Corp. (TSX:LABS) (OTCQX:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know
May 17, 2021
MediPharm Labs Corp. (TSX:LABS) (OTCQX:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.